|
Secondary prevention
Citations 321-330 of 568 total displayed.
|
Past content
(since Feb 1999):
|
- Review: Current Perspective
Influenza and Cardiovascular Disease: A New Opportunity for Prevention and the Need for Further Studies
- Mohammad Madjid, Morteza Naghavi, Silvio Litovsky, and S. Ward Casscells
Circulation 2003;108:2730-2736; published online before print as doi:10.1161/01.CIR.0000102380.47012.92
[Full text]
- Mini-Review: Expert Opinions
Should Evidence-Based Proof of Drug Efficacy Be Extrapolated to a "Class of Agents"?
- Curt D. Furberg and Bruce M. Psaty
Circulation 2003;108:2608-2610, doi:10.1161/01.CIR.0000090572.51900.92
[Full text]
- Correspondence
Preventive Use of N-3 Fatty Acids • Response
- William S. Harris, James H. O’Keefe, Jr, and Scott M. Grundy
Circulation 2003;108:e139, doi:10.1161/01.CIR.0000099902.61378.96
[Full text]
- Clinical Investigations and Reports
Comparison of the Associations of Apolipoprotein B and Low-Density Lipoprotein Cholesterol With Other Cardiovascular Risk Factors in the Insulin Resistance Atherosclerosis Study (IRAS)
- Ken Williams, Allan D. Sniderman, Naveed Sattar, Ralph D’Agostino, Jr, Lynne E. Wagenknecht, and Steven M. Haffner
Circulation 2003;108:2312-2316; published online before print as doi:10.1161/01.CIR.0000097113.11419.9E
[Abstract]
[Full text]
- Articles
Influenza and Cardiovascular Disease. A New Opportunity for Prevention and the Need for Further Studies
- Mohammad Madjid, Morteza Naghavi, Silvio Litovsky, and S. Ward Casscells
Circulation published November 10, 2003, doi:10.1161/01.CIR.0000102380.47012.92
[Abstract]
- Brief Rapid Communications
Effects of Statins on Platelet Inhibition by a High Loading Dose of Clopidogrel
- Iris Müller, Felicitas Besta, Christian Schulz, Zhongyan Li, Steffen Massberg, and Meinrad Gawaz
Circulation 2003;108:2195-2197; published online before print as doi:10.1161/01.CIR.0000099507.32936.C0
[Abstract]
[Full text]
- Articles
Comparison of the Associations of Apolipoprotein B and Low-Density Lipoprotein Cholesterol With Other Cardiovascular Risk Factors in the Insulin Resistance Atherosclerosis Study (IRAS)
- Ken Williams, Allan D. Sniderman, Naveed Sattar, Ralph D’Agostino, Jr, Lynne E. Wagenknecht, and Steven M. Haffner
Circulation published October 27, 2003, doi:10.1161/01.CIR.0000097113.11419.9E
[Abstract]
- Articles
Effects of Statins on Platelet Inhibition by a High Loading Dose of Clopidogrel
- Iris Müller, Felicitas Besta, Christian Schulz, Zhongyan Li, Steffen Massberg, and Meinrad Gawaz
Circulation published October 20, 2003, doi:10.1161/01.CIR.0000099507.32936.C0
[Abstract]
- Clinical Investigations
Effects of Aspirin Dose When Used Alone or in Combination With Clopidogrel in Patients With Acute Coronary Syndromes: Observations From the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Study
- Ron J.G. Peters, Shamir R. Mehta, Keith A.A. Fox, Feng Zhao, Basil S. Lewis, Steven L. Kopecky, Rafael Diaz, Patrick J. Commerford, Vicent Valentin, Salim Yusuf for the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Trial Investigators
Circulation 2003;108:1682-1687; published online before print as doi:10.1161/01.CIR.0000091201.39590.CB
[Abstract]
[Full text]
- Clinical Investigations and Reports
High-Dose Atorvastatin Enhances the Decline in Inflammatory Markers in Patients With Acute Coronary Syndromes in the MIRACL Study
- Scott Kinlay, Gregory G. Schwartz, Anders G. Olsson, Nader Rifai, Sally J. Leslie, William J. Sasiela, Michael Szarek, Peter Libby, Peter Ganz for the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators
Circulation 2003;108:1560-1566; published online before print as doi:10.1161/01.CIR.0000091404.09558.AF
[Abstract]
[Full text]
|
|
